Home300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Nakaraang pagsara
¥15.59
Sakop ng araw
¥15.31 - ¥15.67
Sakop ng taon
¥13.10 - ¥21.12
Market cap
17.49B CNY
Average na Volume
12.41M
P/E ratio
-
Dividend yield
0.58%
Primary exchange
SHE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 671.38M | -17.74% |
Gastos sa pagpapatakbo | 425.29M | -2.76% |
Net na kita | 11.62M | -93.74% |
Net profit margin | 1.73 | -92.40% |
Kita sa bawat share | — | — |
EBITDA | 212.79M | -40.14% |
Aktuwal na % ng binabayarang buwis | -3,472.08% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.65B | 431.20% |
Kabuuang asset | 14.13B | -2.63% |
Kabuuang sagutin | 4.52B | -5.87% |
Kabuuang equity | 9.61B | — |
Natitirang share | 1.12B | — |
Presyo para makapag-book | 1.81 | — |
Return on assets | 2.39% | — |
Return on capital | 2.94% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 11.62M | -93.74% |
Cash mula sa mga operasyon | 286.87M | 60.54% |
Cash mula sa pag-invest | 676.05M | 357.44% |
Cash mula sa financing | -44.23M | -4.17% |
Net change in cash | 918.51M | 825.91% |
Malayang cash flow | -1.08B | 43.85% |
Tungkol
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Itinatag
Set 8, 1992
Website
Mga Empleyado
1,913
